Telemedicine and remote management of patients with heart failure

Advances in telecommunication technologies have created new opportunities to provide telemedical care as an adjunct to medical management of patients with heart failure. Meta-analyses suggest that telemedicine can reduce morbidity and mortality in such patients; however, two prospective clinical trials not included in the analyses do not support these findings. Therefore, the effectiveness of telemedicine in heart failure is not established. Telemedicine approaches range from computer-based support systems to programmes led by nurses and physicians. Standardisation and appropriate classification of telemedical systems are needed to enable accurate interpretation of clinical trials. Here we propose a classification of four generations of telemedicine in heart failure. Not all approaches are the same and not every patient with heart failure will need telemedicine. Crisis prevention and treatment, and stabilisation and self-empowerment of patients are focuses of telemedicine in heart failure. The profile of patients who can potentially benefit from telemedicine is unknown and should be investigated in adequately powered randomised clinical trials. We are optimistic that telemedicine is an efficient approach and will become an important feature of management in heart failure.

[1]  John G F Cleland,et al.  Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans‐European Network‐Home‐Care Management System (TEN‐HMS) study , 2008, European journal of heart failure.

[2]  L. Tavazzi,et al.  Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. , 2011, European heart journal.

[3]  Michael Böhm,et al.  Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure: The Telemedical Interventional Monitoring in Heart Failure Study , 2011, Circulation.

[4]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[5]  Akshay S. Desai,et al.  Connecting the circle from home to heart-failure disease management. , 2010, The New England journal of medicine.

[6]  J. Cleland,et al.  Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[7]  J Taylor,et al.  Focused update of the ESC Guidelines on device therapy in heart failure. , 2010, European heart journal.

[8]  S. Winkler,et al.  A new telemonitoring system intended for chronic heart failure patients using mobile telephone technology--feasibility study. , 2011, International journal of cardiology.

[9]  L. Stevenson,et al.  CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. , 2011, Journal of cardiac failure.

[10]  L. B. E. A. Hoeks,et al.  Systematic Review Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review , 2011 .

[11]  C. Lau,et al.  Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.

[12]  H. Krumholz,et al.  Telemonitoring in patients with heart failure. , 2010, The New England journal of medicine.

[13]  A. de Silvestri,et al.  A meta-analysis of remote monitoring of heart failure patients. , 2009, Journal of the American College of Cardiology.

[14]  A. Rigby,et al.  Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. , 2005, Journal of the American College of Cardiology.

[15]  Ayesha Hasan,et al.  Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. , 2011, American heart journal.

[16]  Malcolm Clarke,et al.  Systematic review of studies on telemonitoring of patients with congestive heart failure: a meta-analysis , 2011, Journal of telemedicine and telecare.

[17]  Jeroen J. Bax,et al.  2010 Focused Update of ESC Guidelines on device therapy in heart failure , 2010, European journal of heart failure.

[18]  M. Middeke,et al.  Einfluss einer telemedizinisch unterstützten Betreuung auf Gesamtbehandlungskosten und Mortalität bei chronischer Herzinsuffizienz , 2007 .

[19]  M. Middeke,et al.  [Impact of telemetric management on overall treatment costs and mortality rate among patients with chronic heart failure]. , 2007, Deutsche medizinische Wochenschrift.

[20]  Eric B. Allely,et al.  Synchronous and asynchronous telemedicine , 1995, Journal of Medical Systems.

[21]  Simon Stewart,et al.  Structured telephone support or telemonitoring programmes for patients with chronic heart failure , 2010, The Cochrane database of systematic reviews.

[22]  Valérie Santschi,et al.  Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring , 2007, European Journal of Clinical Pharmacology.

[23]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[24]  J. Cleland,et al.  Enlisting the help of the largest health care workforce--patients. , 2010, JAMA.

[25]  William T. Abraham,et al.  Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.

[26]  L. Hood,et al.  Predictive, personalized, preventive, participatory (P4) cancer medicine , 2011, Nature Reviews Clinical Oncology.

[27]  P. Ponikowski,et al.  Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure , 2010, European journal of heart failure.

[28]  M. Zile,et al.  Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.

[29]  W Frank Peacock,et al.  State of the art: Using natriuretic peptide levels in clinical practice , 2008, European journal of heart failure.